Study of FGFR3 Mutants and Their Effect on STAT1 Activation in Skeletal Dysplasia
Author Information
Author(s): Krejci Pavel, Salazar Lisa, Kashiwada Tamara A., Chlebova Katarina, Salasova Alena, Thompson Leslie Michels, Bryja Vitezslav, Kozubik Alois, Wilcox William R.
Primary Institution: Masaryk University, Brno, Czech Republic
Hypothesis
Only specific FGFR3 mutants significantly activate STAT1 in skeletal dysplasia.
Conclusion
The K650M and K650E FGFR3 mutants are the only ones that significantly activate STAT1, while other mutants do not.
Supporting Evidence
- Only K650M and K650E-FGFR3 mutants caused strong STAT1 activation.
- Other FGFR3 mutants showed weak or no activation of STAT1.
- ERK MAP kinase activation was induced by all six FGFR3 mutants.
Takeaway
Some changes in a gene called FGFR3 can make it work differently, but only a couple of these changes really turn on a helper protein called STAT1.
Methodology
The study compared the ability of six FGFR3 mutants to activate STAT1 and ERK MAP kinase in various cell types.
Limitations
The study primarily focused on a limited number of FGFR3 mutants, which may not represent all cases of skeletal dysplasia.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website